Skip to main content

Table 1 Clinical characteristics of the patients analyzed

From: Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy

Gender

Number

(%)

Male

12

  70.6%

Female

5

  29.4%

Histology

Number

(%)

Adenocarcinoma

2

  11.8%

Squamous cell

13

  76.4%

Other

2

  11.8%

Initial cT

Number

(%)

cT1

1

  5.9%

cT2

3

  17.6%

cT3

4

  23.5%

cT4

9

  53%

Age (years)

Median

Range

54

41 – 78